We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of Curcumin on Postprandial Blood Glucose, and Insulin in Healthy Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01029327
Recruitment Status : Completed
First Posted : December 9, 2009
Last Update Posted : December 9, 2009
Sponsor:
Information provided by:

Study Description
Brief Summary:
Previous animal studies have shown that extracts of Curcumin lowers blood glucose.

Condition or disease
Diabetes

Detailed Description:
To study the effect of curcumin on postprandial blood glucose and plasma concentrations of insulin in fifteen healthy subjects.

Study Design

Study Type : Observational
Observational Model: Case-Crossover
Time Perspective: Cross-Sectional
Study Start Date : June 2009
Study Completion Date : September 2009
Groups and Cohorts

Group/Cohort
Healthy subjects


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Healthy subjects recruited from the population in southern Sweden.
Criteria

Inclusion Criteria:

  • Fifteen healthy subjects without symptoms or a history of gastrointestinal disease, abdominal surgery or diabetes mellitus, were included in this crossover study.

Exclusion Criteria:

  • Connective tissue disease or cerebrovascular or endocrine disease.
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01029327


Locations
Sweden
Department of Medicine, Malmö University Hospital
Malmö, Sweden, 205 02
Sponsors and Collaborators
Skane University Hospital
More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT01029327     History of Changes
Other Study ID Numbers: 353/2008c
First Posted: December 9, 2009    Key Record Dates
Last Update Posted: December 9, 2009
Last Verified: June 2009